XTX Topco’s KalVista Pharmaceuticals KALV Stock Holding History

XTX Topco’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-79,118	Closed	-$1.59M	–	4437
2026 Q1	$1.59M	Buy	79,118 +52,610	+198%	+$848K	0.03%	1026
2025 Q4	$428K	Buy	+26,508	New	+$351K	0.01%	1752
2025 Q1	–	Sell	-31,573	Closed	-$267K	–	2742
2024 Q4	$267K	Buy	+31,573	New	+$327K	0.02%	1316

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

XTX Topco's KALV Position: Q2 2026 in Review

XTX Topco sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 79,118 shares — an estimated $1.59M sold.

XTX Topco first reported a position in KALV in Q4 2024 and held it in 3 quarters. The position peaked at $1.59M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

XTX Topco reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 79,118 KalVista Pharmaceuticals shares in Q2 2026, an estimated $1.59M.
XTX Topco first reported a position in KalVista Pharmaceuticals in Q4 2024 and held it in 3 quarters.
XTX Topco's KalVista Pharmaceuticals position peaked at $1.59M in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.